Express Scripts 2012 Drug Trend Report

Express Scripts 2012 Drug Trend Report

Today, Express Scripts released its 2012 Drug Trend Report, based on Express Scripts claims data for 100 million Americans.  Of special interest to UBC's manufacturer customers, is the information provided on specialty prescription-drug spending.  While affecting less than 2% of the general population, specialty conditions in 2012 accounted for 24.5% of the country’s total drug spend within the pharmacy benefit, the highest percentage on record.

The report reviews prescription drug cost and utilization trends for all therapy classes across commercial, Medicare, and Medicaid populations. The report looks back at the last 20 years of pharmacy and predicts what innovations are likely to occur in the next 20.

This web-based report is user-friendly and filled with information important to you and your products.  Mark it as a favorite!